Abstract
Hypertension has been the single most important risk factor for heart failure until the last few decades. Now, it is frequently claimed that atherosclerotic coronary artery disease dominates as the major underlying cause, and hypertension is of lesser importance. We here review evidence regarding the contribution of hypertension to heart failure in the recent decades. It is not possible, in our view, to be confident of the relative importance of hypertension and coronary artery disease since there are significant limitations in the available data. The often-questionable diagnostic criteria used in defining heart failure is one such limitation. The absence or inadequacy of blood pressure recordings over the years prior to a diagnosis of heart failure seriously hinders the reaching of firm conclusions in many reports. Extrapolations from aetiological observations in one racial group to those in other racial groups, and from highly selected study groups in tertiary referral centres to patients with heart failure in primary and secondary care, may not be justified. Finally, the situation of heart failure primarily due to impaired left ventricular diastolic function, where hypertension is a frequent precursor, is often ignored in discussions of aetiology. Our view is that hypertension remains and probably is the single most, important modifiable risk factor for cardiac failure in some races and countries, where the dominant cardiac abnormality is left ventricular diastolic dysfunction. The situation is less clear for patients with heart failure primarily due to left ventricular systolic dysfunction.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Smirk FH . The clinical manifestations of hypertension. In: Smirk FH (ed). High Arterial Pressure. Blackwell: Oxford, 1957, pp 83–88.
Kannel WB et al. Role of blood pressure in the development of congestive heart failure. The Framingham study. N Engl J Med 1972; 287: 781–787.
Levy D et al. The progression from hypertension to congestive heart failure. JAMA 1996; 275: 1557–1562.
Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. JAMA 1967; 202: 1028–1034.
Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. JAMA 1970; 213: 1143–1152.
Moser M, Hebert PR . Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol 1996; 27: 1214–1218.
Clawson BJ . Incidence of types of heart disease among 30,265 autopsies, with special reference to age and sex. Am Heart J 1941; 22: 607–624.
Wartman WB, Hellerstein HK . The incidence of heart disease in 2,000 consecutive autopsies. Ann Intern Med 1943; 28: 41–65.
Vasan RS, Levy D . The role of hypertension in the pathogenesis of heart failure. A clinical mechanistic overview. Arch Intern Med 1996; 156: 1789–1796.
Lloyd-Jones DM et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 2002; 106: 3068–3072.
Haider AW, Larson MG, Franklin SS, Levy D . Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med 2003; 138: 10–16.
Kostis JB et al. Association of increased pulse pressure with the development of heart failure in SHEP. Am J Hypertens 2001; 14: 798–803.
Chae CU et al. Increased pulse pressure and risk of heart failure in the elderly. JAMA 1999; 281: 634–639.
Himmelmann A . Hypertension: an important precursor of heart failure. Blood Press 1999; 8: 253–260.
Frohlich ED . Hypertension: our major challenges. Hypertension 2001; 38: 990–991.
Teerlink JR, Goldhaber SZ, Pfeffer MA . An overview of contemporary etiologies of congestive heart failure. Am Heart J 1991; 121: 1852–1853.
Gheorghiade M, Bonow RO . Chronic heart failure in the United States. A manifestation of coronary artery disease. Circulation 1998; 97: 282–289.
Johnstone DE et al. Diagnosis and management of heart failure. Can J Cardiol 1994; 10: 613–631.
Petrie MC, Berry C, Stewart S, McMurray JJV . Failing ageing hearts. Eur Heart J 2001; 22: 1978–1990.
He J et al. Risk factors for congestive heart failure in US men and women. Arch Intern Med 2001; 161: 996–1002.
Coronal R, de Groot JR, van Lieshout JJ . Defining heart failure. Cardiovasc Res 2001; 50: 419–422.
Remes J, Miettinen H, Reunanen A, Pyorala K . Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991; 12: 315–321.
Davies MK et al. Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study. Lancet 2001; 358: 439–444.
Marantz PR, Alderman MH, Tobin JN . Diagnostic heterogeneity in clinical trials for congestive heart failure. Ann Intern Med 1988; 109: 55–61.
Goff DC et al. Congestive heart failure in the United States. Is there more than meets the I(CD Code)? The Corpus Christi Heart Project. Arch Intern Med 2000; 160: 197–202.
Psaty BM, Boineau R, Kuller LH, Luepker RV . The potential costs of upcoding for heart failure in the United States. Am J Cardiol 1999; 84: 108–109.
O’Connor CM et al. Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function. Am J Cardiol 2000; 86: 863–867.
Nicholls MG . Hypertension, hypertrophy, heart failure. Heart 1996; 76(Suppl 3): 92–97.
Fox KF et al. Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J 2001; 22: 228–236.
Wilhelmsen L, Rosengren A, Eriksson H, Lappas G . Heart failure in the general population of men—morbidity, risk factors and prognosis. J Intern Med 2001; 249: 253–261.
Kupari M et al. Congestive heart failure in old age: prevalence, mechanisms and 4-year prognosis in the Helsinki Ageing Study. J Intern Med 1997; 241: 387–394.
Chobanian AV et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003; 289: 2560–2572.
Guidelines Committee. 2003 European Society of Hypertension—European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011–1053.
Andersson B, Waagstein F . Spectrum and outcome of congestive heart failure in a hospitalized population. Am Heart J 1993; 126: 632–640.
Cleland JGF et al. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 2002; 360: 1631–1639.
Kitzman DW et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 2002; 288: 2144–2150.
Bourassa MG et al. Natural history and patterns of current practice in heart failure. J Am Coll Cardiol 1993; 22(Suppl A): 14A–19A.
Alexander M et al. Hospitalization for congestive heart failure. JAMA 1995; 274: 1037–1042.
Aronow WS, Ahn C, Kronzon I . Comparison of incidences of congestive heart failure in older African-Americans, Hispanics, and whites. Am J Cardiol 1999; 84: 611–612.
Mathew J et al. Etiology and characteristics of congestive heart failure in blacks. Am J Cardiol 1996; 78: 1447–1450.
Vaccarino V et al. Differences between African Americans and whites in the outcome of heart failure: evidence for a greater functional decline in African Americans. Am Heart J 2002; 143: 1058–1067.
Sanderson JE, Tse T-F . Heart failure: a global disease requiring a global response. Heart 2003; 89: 585–586.
Obasohan AO, Ajuyah CO . How common is heart failure due to systemic hypertension alone in hospitalized Nigerians? J Hum Hypertens 1996; 10: 801–804.
Amoah AGB, Kallen C . Aetiology of heart failure as seen from a national cardiac referral center in Africa. Cardiology 2000; 93: 11–18.
Sanderson JE et al. The aetiology of heart failure in the Chinese population of Hong Kong—a prospective study of 730 consecutive patients. Int J Cardiol 1995; 51: 29–35.
Agarwal AK, Venugopalan P, de Bono D . Prevalence and aetiology of heart failure in an Arab population. Eur J Heart Fail 2001; 3: 301–305.
Cubillos-Garzon LA, Casas JP, Morillo CA, Bautista LE . Congestive heart failure in Latin America: the next epidemic. Am Heart J 2004; 147: 412–417.
Ghali JK . Contemporary issues in heart failure. Am Heart J 1999; 138: 5–8.
Senni M et al. Congestive heart failure in the community. A study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998; 98: 2282–2289.
Masoudi FA et al. Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure. Am Heart J 2003; 146: 250–257.
Vasan RS, Levy D . Defining diastolic heart failure. A call for standardized diagnostic criteria. Circulation 2000; 101: 2118–2121.
Banerjee P et al. Diastolic heart failure: neglected or misdiagnosed? J Am Coll Cardiol 2002; 39: 138–141.
Angeja BG, Grossman W . Evaluation and management of diastolic heart failure. Circulation 2003; 107: 659–663.
Klapholz M et al. Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction. J Am Coll Cardiol 2004; 43: 1432–1438.
Yip GWK, Ho PPY, Woo KS, Sanderson JE . Comparison of frequencies of left ventricular systolic and diastolic heart failure in Chinese living in Hong Kong. Am J Cardiol 1999; 84: 563–567.
Masoudi FA et al. Gender, age and heart failure with preserved left ventricular systolic function. J Am Coll Cardiol 2003; 41: 217–223.
Pilz B, Brasen J-H, Schneider W, Luft FC . Obesity and hypertension-induced restrictive cardiomyopathy. A harbinger of things to come. Hypertension 2004; 43: 911–917.
Macdonald PS, O’Rourke MF . Cardiovascular ageing and heart failure. Med J Aust 1998; 169: 480–484.
Brush JE et al. Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 1988; 319: 1302–1307.
Strauer BE . Significance of coronary circulation in hypertensive heart disease for development and prevention of heart failure. Am J Cardiol 1990; 65: 34G–41G.
Schafer S, Kelm M, Mingers S, Strauer BE . Left ventricular remodeling impairs coronary flow reserve in hypertensive patients. J Hypertens 2002; 20: 1431–1437.
McDonagh TA et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 1997; 350: 829–833.
Zugck C et al. Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure. J Am Coll Cardiol 2002; 39: 1615–1622.
Vogt M, Strauer BE . Systolic ventricular dysfunction and heart failure due to coronary microangiopathy in hypertensive heart disease. Am J Cardiol 1995; 76: 48D–53D.
Frohlich ED . Risk mechanisms in hypertensive heart disease. Hypertension 1999; 34: 782–789.
Scheler S, Motz WH . The inter-relationship between hypertension and ischaemic heart disease. Eur Heart J 1999; 1(Suppl I): I2–I6.
Agabiti-Rosei E, Muiesan ML . Hypertension and the heart: from left ventricular hypertrophy to ischaemia to congestive heart failure. In: Birkenhager WH, Robertson JIS, Zanchetti A (eds). Handbook of Hypertension, Vol. 22. Elsevier: Amsterdam, 2004, pp 339–366.
Kenchaiah S et al. Effect of antecedent hypertension on subsequent left ventricular dilatation after acute myocardial infarction (from the Survival and Ventricular Enlargement Trial). Am J Cardiol 2004; 94: 1–8.
Richards AM et al. Antecedent hypertension and heart failure after myocardial infarction. J Am Coll Cardiol 2002; 39: 1182–1188.
French JK et al. Association of angiographically detected coronary artery disease with low levels of high-density lipoprotein cholesterol and systemic hypertension. Am J Cardiol 1993; 71: 505–510.
Natali A et al. Coronary artery disease and arterial hypertension: clinical, angiographic and follow-up data. J Intern Med 2000; 247: 219–230.
UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J 1998; 317: 703–713.
Primatesta P, Poulter NR . Hypertension management and control among English adults aged 65 years and older in 2000 and 2001. J Hypertens 2004; 22: 1093–1098.
Lloyd-Jones DM et al. Differential control of systolic and diastolic blood pressure. Factors associated with lack of blood pressure control in the community. Hypertension 2000; 36: 594–599.
Meissner I et al. Detection and control of high blood pressure in the community. Do we need a wake-up call? Hypertension 1999; 34: 466–471.
Kastarinen MJ et al. Trends in blood pressure levels and control of hypertension in Finland from 1982 to 1997. J Hypertens 1998; 16: 1379–1387.
Johannesson M . The cost-effectiveness of hypertension in Sweden. Pharmaco Economics 1995; 7: 242–250.
MacMahon et al. Blood pressure, stroke, and coronary heart disease. Part I. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765–774.
Collins R et al. Blood pressure, stroke and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview and randomized drug trials in their epidemiological context. Lancet 1990; 335: 827–838.
Rodgers A, Lawes C, MacMahon S . Reducing the global burden of blood pressure-related cardiovascular disease. J Hypertens 2000; 18(Suppl 1): S3–S6.
Smith SC et al. Principles for national and regional guidelines on cardiovascular disease prevention. A scientific statement from the World Heart and Stroke Forum. Circulation 2004; 109: 3112–3121.
Ho KKL et al. Survival after the onset of congestive heart failure in Framingham heart study subjects. Circulation 1993; 88: 107–115.
Ho KKL, Pinsky JL, Kannel WB, Levy D . The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol 1993; 22(Suppl A): 6A–13A.
Acknowledgements
We are grateful to Ms Reena John for secretarial assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kazzam, E., Ghurbana, B., Obineche, E. et al. Hypertension — still an important cause of heart failure?. J Hum Hypertens 19, 267–275 (2005). https://doi.org/10.1038/sj.jhh.1001820
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1001820
Keywords
This article is cited by
-
Prevalence, awareness, treatment and control of hypertension in Galicia (Spain) and association with related diseases
Journal of Human Hypertension (2007)
-
Towards understanding the aetiology and pathophysiology of human hypertension: where are we now?
Journal of Human Hypertension (2006)
-
Towards improving the clinical assessment and management of human hypertension: an overview from this Journal
Journal of Human Hypertension (2006)
-
Association between cardiac disorders and a decades-previous history of diphtheria
European Journal of Clinical Microbiology and Infectious Diseases (2006)
-
How far can population epidemiology contribute to defining the relationship between hypertension and left ventricular systolic dysfunction?
Journal of Human Hypertension (2005)